Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

MYGN

Myriad Genetics, Inc.

Apr 19 • 09:57AM ET

18.60

Dollar change +0.09
Percentage change 0.51	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IJR VTI VB IWM VBR VXF IWN IBB IJS IJT

Index	RUT	P/E	-	EPS (ttm)	-3.20	Insider Own	4.29%	Shs Outstand	89.90M	Perf Week	-4.83%
Market Cap	1.67B	Forward P/E	72.96	EPS next Y	0.26	Insider Trans	-1.53%	Shs Float	86.02M	Perf Month	-16.34%
Income	-263.30M	PEG	-	EPS next Q	-0.10	Inst Own	101.45%	Short Float	6.59%	Perf Quarter	-8.39%
Sales	753.20M	P/S	2.22	EPS this Y	109.26%	Inst Trans	1.69%	Short Ratio	9.17	Perf Half Y	23.54%
Book/sh	8.71	P/B	2.14	EPS next Y	920.00%	ROA	-20.54%	Short Interest	5.67M	Perf Year	-18.43%
Cash/sh	1.58	P/C	11.77	EPS next 5Y	-8.20%	ROE	-31.55%	52W Range	13.82 - 24.21	Perf YTD	-2.80%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-28.65%	52W High	-23.15%	Beta	1.99
Dividend TTM	-	Quick Ratio	1.87	Sales past 5Y	4.63%	Gross Margin	62.96%	52W Low	34.62%	ATR (14)	0.79
Dividend Ex-Date	-	Current Ratio	2.01	EPS Y/Y TTM	-131.34%	Oper. Margin	-19.33%	RSI (14)	30.57	Volatility	4.11% 3.79%
Employees	2700	Debt/Eq	0.19	Sales Y/Y TTM	11.03%	Profit Margin	-34.96%	Recom	2.85	Target Price	23.67
Option/Short	Yes / Yes	LT Debt/Eq	0.17	EPS Q/Q	30.17%	Payout	-	Rel Volume	0.39	Prev Close	18.51
Sales Surprise	0.92%	EPS Surprise	181.69%	Sales Q/Q	10.57%	Earnings	Feb 27 AMC	Avg Volume	617.70K	Price	18.60
SMA20	-9.18%	SMA50	-13.87%	SMA200	-3.50%	Trades		Volume	28,247	Change	0.51%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-21-23	Resumed	Piper Sandler	Neutral	$23
Dec-19-23	Initiated	Wells Fargo	Equal Weight	$20
Dec-14-23	Initiated	Guggenheim	Buy	$23
Dec-13-23	Initiated	Wolfe Research	Outperform	$28
Jul-05-23	Resumed	JP Morgan	Underweight	$18
May-23-23	Upgrade	Goldman	Sell → Buy	$18 → $25
Jan-18-23	Upgrade	Raymond James	Mkt Perform → Outperform	$25
Oct-06-22	Initiated	Stephens	Equal-Weight	$22
Oct-15-21	Resumed	Cowen	Market Perform	$33
Jun-15-21	Initiated	Raymond James	Mkt Perform
Jun-03-21	Initiated	Goldman	Sell	$25
Sep-26-19	Downgrade	BofA/Merrill	Neutral → Underperform	$30 → $28
Aug-14-19	Downgrade	Piper Jaffray	Overweight → Neutral	$45 → $40
Aug-02-19	Upgrade	BofA/Merrill	Underperform → Neutral
Aug-01-19	Upgrade	Barclays	Underweight → Equal Weight	$18 → $40
Jul-29-19	Downgrade	Needham	Strong Buy → Hold
Jul-09-19	Downgrade	Cowen	Outperform → Market Perform
Mar-12-19	Reiterated	Needham	Strong Buy	$37 → $41
Jan-03-19	Initiated	Needham	Strong Buy	$36
Nov-30-18	Upgrade	Goldman	Sell → Neutral

Show Previous Ratings

Apr-17-24 08:00AM	Nearly Half of Americans Say They've Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor (GlobeNewswire)
Apr-16-24 09:15AM	New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel Prenatal Screen (GlobeNewswire)
Apr-11-24 10:00AM	Myriad Genetics (MYGN) Announces Favorable Research Results (Zacks)
Apr-09-24 09:10AM	Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now (Zacks)
08:00AM	Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing (GlobeNewswire)
11:30AM	Loading…
Mar-28-24 11:30AM	Why Is Myriad (MYGN) Down 1% Since Last Earnings Report? (Zacks)
Mar-27-24 07:51AM	Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay (Zacks)
Mar-21-24 09:40PM	Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date (GlobeNewswire)
Mar-20-24 04:05PM	Myriad Genetics Announces Patent Granted for SneakPeek Snap Device (GlobeNewswire)
Mar-01-24 09:41AM	Myriad Genetics (MYGN) to Evaluate MRD Testing With New Pact (Zacks) +5.97%
Feb-28-24 02:45PM	Analyst Report: Myriad Genetics, Inc. (Morningstar Research) -8.04%
11:24AM	Q4 2023 Myriad Genetics Inc Earnings Call (Thomson Reuters StreetEvents)
10:24AM	Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:50AM	Myriad Genetics (MYGN) Q4 Earnings Top Estimate, Margins Down (Zacks)
Feb-27-24 07:00PM	Myriad (MYGN) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
06:30PM	Loading…
06:30PM	Myriad Genetics (MYGN) Tops Q4 Earnings and Revenue Estimates (Zacks)
04:42PM	Myriad Genetics Inc (MYGN) Reports 11% Revenue Growth in Q4 and Full-Year 2023 (GuruFocus.com)
04:05PM	Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance (GlobeNewswire)
09:15AM	Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3 (GlobeNewswire)
Feb-26-24 09:16AM	Wall Street's Insights Into Key Metrics Ahead of Myriad (MYGN) Q4 Earnings (Zacks)
Feb-21-24 04:05PM	Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 (GlobeNewswire)
Feb-16-24 07:05AM	Larry Robbins' Glenview Capital Management Bolsters Stake in Myriad Genetics Inc (GuruFocus.com)
Feb-15-24 04:05PM	Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women's Health (GlobeNewswire)
Feb-01-24 09:25AM	Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics (GlobeNewswire)
Jan-30-24 05:00PM	Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology (GlobeNewswire)
Jan-25-24 07:05PM	Analyst Report: Myriad Genetics, Inc. (Morningstar Research)
Jan-22-24 08:55AM	Myriad's (MYGN) New Acquisition to Boost Precision Oncology Arm (Zacks) +5.17%
Jan-18-24 06:10PM	Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics (GlobeNewswire)
Jan-09-24 04:05PM	Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SSO (GlobeNewswire)
Jan-04-24 11:10AM	Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now (Zacks)
04:05PM	Loading…
Jan-03-24 04:05PM	Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-21-23 03:05PM	Genetic Testing Pioneer Myriad Genetics' Evolution Draws Analyst Attention Amid New Product(s) Anticipation (Benzinga)
09:17AM	Myriad Genetics' (MYGN) New Platform to Advance Cancer Care (Zacks)
08:30AM	Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor; Reiterates Previously Issued Financial Guidance (GlobeNewswire)
Dec-20-23 08:00AM	Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform to Advance Patient Care (GlobeNewswire)
Dec-14-23 08:22AM	Myriad Genetics' (MYGN) New Partnerships Aid Amid FX Woes (Zacks)
Dec-06-23 11:30AM	Why Is Myriad (MYGN) Up 3% Since Last Earnings Report? (Zacks)
Nov-21-23 10:54AM	Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now (Zacks)
Nov-20-23 04:05PM	Myriad Genetics Celebrates One Million SneakPeek Results Shared with Expectant Parents (GlobeNewswire)
11:18AM	Myriad Genetics (MYGN) Expands Pharma Services With New Pact (Zacks)
Nov-16-23 04:05PM	Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers (GlobeNewswire)
Nov-09-23 07:00AM	Myriad Genetics to Participate in Stephens Annual Investment Conference (GlobeNewswire) -8.94%
Nov-08-23 09:20PM	Myriad Genetics Announces Pricing of Upsized Offering of Common Stock (GlobeNewswire)
04:10PM	Myriad Genetics Announces Proposed Offering of $100 Million of Shares of Common Stock (GlobeNewswire)
Nov-07-23 02:30PM	Analyst Report: Myriad Genetics, Inc. (Morningstar Research) +8.69%
10:24AM	Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
10:09AM	Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q3 (Zacks)
Nov-06-23 07:00PM	Myriad (MYGN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
04:59PM	Myriad Genetics Inc (MYGN) Reports 23% YoY Revenue Growth in Q3 2023 (GuruFocus.com)
04:36PM	Myriad: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth; Raises 2023 Revenue Guidance and Introduces 2024 Revenue Guidance (GlobeNewswire)
Nov-04-23 03:02AM	Insider Sell: CFO Richard Riggsbee Sells 30,000 Shares of Myriad Genetics Inc (GuruFocus.com)
Nov-03-23 07:04PM	Analyst Report: Myriad Genetics, Inc. (Morningstar Research) +6.51%
Nov-01-23 09:00AM	Myriad Genetics Appoints Sam Raha as Chief Operating Officer (GlobeNewswire)
Oct-31-23 04:05PM	Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023 (GlobeNewswire) +7.60%
Oct-30-23 03:46PM	Top 20 Genomics Companies in the World (Insider Monkey)
Oct-26-23 08:00AM	QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer (GlobeNewswire)
Oct-20-23 10:31AM	Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research (PR Newswire)
Oct-09-23 06:56PM	Analyst Report: Myriad Genetics, Inc. (Morningstar Research)
Sep-29-23 11:44AM	Is Myriad Genetics (MYGN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
Sep-28-23 04:59PM	BREAST CANCER AWARENESS MONTH: NEW CANCER RISK SURVEY REVEALS RISK FACTORS ARE WIDELY MISUNDERSTOOD (PR Newswire)
07:00AM	New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood (GlobeNewswire)
Sep-22-23 11:51AM	Is Myriad Genetics (MYGN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
Sep-20-23 07:42AM	Myriad Genetics (MYGN) Secures Key Milestones in Illumina Tie-Up (Zacks)
Sep-19-23 09:00AM	Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials (GlobeNewswire)
07:00AM	Myriad Genetics Issues 2022 Environmental, Social and Governance Report (GlobeNewswire)
Sep-18-23 08:00AM	Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer (GlobeNewswire)
Sep-12-23 11:41AM	Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now (Zacks)
Sep-08-23 11:49AM	Is Myriad Genetics (MYGN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
Sep-07-23 11:30AM	Why Is Amicus Therapeutics (FOLD) Down 6.8% Since Last Earnings Report? (Zacks)
Sep-06-23 04:05PM	Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work (GlobeNewswire)
07:00AM	New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women (GlobeNewswire)
Sep-05-23 08:00AM	Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-23-23 09:48AM	Myriad Genetics (MYGN) Teams Up to Assess Breast Cancer Risk (Zacks)
Aug-22-23 09:00AM	Myriad Genetics and Onsite Womens Health Partner to Help More Women Understand Breast Cancer Risk (GlobeNewswire)
Aug-17-23 04:05PM	Myriad Genetics to Host Investor Day on September 19, 2023 (GlobeNewswire)
Aug-16-23 08:36AM	Myriad Genetics (MYGN) Adds ARR to Prolaris Biomarker Test (Zacks)
Aug-15-23 07:05AM	Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris® (GlobeNewswire)
Aug-11-23 10:34AM	Myriad Genetics (MYGN) Unveils GeneSight Test Enhancement (Zacks) +7.19%
Aug-08-23 04:05PM	Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment (GlobeNewswire)
Aug-07-23 04:05PM	Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status (GlobeNewswire) -9.53%
12:12PM	Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Q2 Loss (Zacks)
Aug-05-23 08:29AM	Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-04-23 09:00PM	Myriad (MYGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -6.98%
07:08PM	Analyst Report: Myriad Genetics, Inc. (Morningstar Research)
07:09AM	Q2 2023 Myriad Genetics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-03-23 06:35PM	Myriad Genetics (MYGN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Myriad Genetics Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Revenue and Adjusted EPS Guidance; Generates the Fourth Consecutive Quarter of Double-Digit Year-Over-Year Testing Volume Growth (GlobeNewswire)
Jul-27-23 04:05PM	Myriad Genetics to Release Second Quarter Financial Results on Aug. 3, 2023 (GlobeNewswire)
Jul-24-23 08:00AM	Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment (GlobeNewswire)
Jul-06-23 08:30AM	Myriad Genetics Announces New $90 Million Asset-Based Credit Facility (GlobeNewswire)
Jun-30-23 11:16AM	Myriad Genetics (MYGN) Test Volume Rises Amid Margin Woe (Zacks)
Jun-28-23 09:32AM	Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now (Zacks)
Jun-21-23 08:00PM	MYGN: What does Argus have to say about MYGN? (Argus Research)
Jun-17-23 07:00AM	3 Gene Testing Stocks to Buy Before They Take Off (InvestorPlace)
Jun-13-23 08:16AM	Myriad Genetics' (MYGN) New Pact to Use MRD Testing Platform (Zacks)
Jun-12-23 08:00AM	Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform (GlobeNewswire)
Jun-07-23 04:05PM	Myriad Genetics to Participate in Goldman Sachs Healthcare Conference (GlobeNewswire)
Jun-01-23 08:00AM	Myriad Genetics Highlights Latest Oncology Portfolio Advancements and New Data at ASCO 2023 (GlobeNewswire)
07:36AM	Shareholders in Myriad Genetics (NASDAQ:MYGN) have lost 44%, as stock drops 3.8% this past week (Simply Wall St.)

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Riggsbee Richard Bryan	Chief Financial Officer	Dec 01 '23	Sale	19.09	30,000	572,835	291,812	Dec 05 04:19 PM
Riggsbee Richard Bryan	Chief Financial Officer	Nov 01 '23	Sale	15.69	30,000	470,622	321,812	Nov 03 05:12 PM
SPIEGELMAN DANIEL K	Director	Jun 02 '23	Sale	23.01	8,638	198,760	40,493	Jun 02 06:15 PM

Open in Screener

WB

Weibo Corp ADR

Apr 19 • 09:58AM ET

7.96

Dollar change -0.10
Percentage change -1.24	%

Communication Services • Internet Content & Information • China • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Index	-	P/E	5.56	EPS (ttm)	1.43	Insider Own	0.04%	Shs Outstand	145.37M	Perf Week	4.33%
Market Cap	1.16B	Forward P/E	3.98	EPS next Y	2.00	Insider Trans	0.00%	Shs Float	145.31M	Perf Month	-7.06%
Income	342.60M	PEG	1.37	EPS next Q	0.36	Inst Own	52.14%	Short Float	7.43%	Perf Quarter	7.93%
Sales	1.76B	P/S	0.66	EPS this Y	-1.59%	Inst Trans	-5.59%	Short Ratio	4.16	Perf Half Y	-27.21%
Book/sh	13.81	P/B	0.58	EPS next Y	8.09%	ROA	4.76%	Short Interest	10.80M	Perf Year	-45.39%
Cash/sh	22.19	P/C	0.36	EPS next 5Y	4.08%	ROE	10.18%	52W Range	7.12 - 15.46	Perf YTD	-19.96%
Dividend Est.	0.40 (5.01%)	P/FCF	-	EPS past 5Y	-10.96%	ROI	6.52%	52W High	-48.50%	Beta	0.42
Dividend TTM	0.00 (0.00%)	Quick Ratio	2.38	Sales past 5Y	1.84%	Gross Margin	78.73%	52W Low	11.78%	ATR (14)	0.37
Dividend Ex-Date	Apr 11, 2024	Current Ratio	2.38	EPS Y/Y TTM	296.59%	Oper. Margin	26.87%	RSI (14)	46.80	Volatility	4.44% 4.18%
Employees	-	Debt/Eq	0.78	Sales Y/Y TTM	-4.17%	Profit Margin	19.47%	Recom	2.04	Target Price	12.17
Option/Short	Yes / Yes	LT Debt/Eq	0.55	EPS Q/Q	-42.77%	Payout	0.00%	Rel Volume	1.05	Prev Close	8.06
Sales Surprise	1.45%	EPS Surprise	-38.43%	Sales Q/Q	3.50%	Earnings	Mar 14 BMO	Avg Volume	2.60M	Price	7.96
SMA20	-2.10%	SMA50	-3.62%	SMA200	-20.99%	Trades		Volume	321,099	Change	-1.24%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-28-24	Downgrade	Goldman	Buy → Neutral
Mar-19-24	Upgrade	UBS	Neutral → Buy	$11.50
Jan-11-24	Downgrade	BofA Securities	Buy → Underperform	$19.50 → $10
Aug-25-23	Downgrade	The Benchmark Company	Buy → Hold
Jun-13-23	Downgrade	UBS	Buy → Neutral	$33 → $15.50
Jan-30-23	Initiated	JP Morgan	Neutral
Jan-09-23	Upgrade	Goldman	Neutral → Buy	$25
Apr-11-22	Resumed	Goldman	Neutral	$37.50
Mar-11-22	Downgrade	UBS	Buy → Neutral	$64 → $27.80
Aug-19-21	Upgrade	Credit Suisse	Neutral → Outperform	$48 → $56
Sep-29-20	Upgrade	CLSA	Outperform → Buy
Apr-22-20	Downgrade	Barclays	Overweight → Equal Weight	$47 → $40
Nov-15-19	Downgrade	CLSA	Buy → Outperform
Nov-14-19	Downgrade	Credit Suisse	Outperform → Neutral
Oct-18-19	Upgrade	Jefferies	Hold → Buy
Oct-04-19	Upgrade	Credit Suisse	Neutral → Outperform
Aug-19-19	Upgrade	CLSA	Outperform → Buy
Aug-05-19	Initiated	Jefferies	Hold
May-28-19	Downgrade	JP Morgan	Overweight → Neutral
May-24-19	Reiterated	The Benchmark Company	Buy	$81 → $51

Show Previous Ratings

Today 04:04AM	Weibo Publishes 2023 Environmental, Social and Governance Report (PR Newswire)
Apr-14-24 12:06AM	25 Biggest Social Media Companies and Platforms for Advertisers (Insider Monkey)
Apr-12-24 11:09AM	10 Most Undervalued Stocks to Buy for Under $20 (Insider Monkey) -6.95%
Apr-08-24 05:45AM	Weibo to Hold Annual General Meeting on May 22, 2024 (PR Newswire)
Apr-01-24 03:32PM	36Kr Holdings Inc. (NASDAQ:KRKR) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:24PM	Loading…
Mar-31-24 10:24PM	INSIGHT-Chinese state media stoked allegation Taiwan's president would flee war (Reuters)
Mar-27-24 06:52AM	Q4 2023 Ryvyl Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-22-24 07:07AM	Netflix's '3 Body Problem' leaves jaws dropped among Chinese viewers (Reuters) -5.18%
Mar-19-24 11:55PM	Apple boss Tim Cook visits Shanghai with China sales under pressure (Reuters)
11:42PM	Apple boss Tim Cook visiting Shanghai (Reuters)
Mar-14-24 09:30AM	Here's What Key Metrics Tell Us About Weibo Corporation (WB) Q4 Earnings (Zacks)
05:00AM	Weibo Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results and Dividend (PR Newswire)
Mar-12-24 11:29PM	UPDATE 3-Devastating blast in China's Hebei kills two, injures 26 (Reuters)
07:43AM	5 Things to Know Before the Stock Market Opens (Investopedia)
Mar-11-24 09:55PM	China's Xiaomi to start first EV deliveries this month (Reuters)
04:00AM	Loading…
Feb-27-24 04:00AM	Weibo Corporation to Report Fourth Quarter and Fiscal Year 2023 Financial Results on March 14, 2024 (PR Newswire)
Feb-23-24 05:27PM	Exit Now! 3 Social Media Stocks to Sell in February 2024 (InvestorPlace)
04:30AM	Russia makes its case to China social media users ahead of Ukraine war anniversary (South China Morning Post)
Feb-20-24 02:38AM	Pork flavored coffee is Starbucks newest China pitch (CNN Business)
Feb-11-24 06:23AM	3 Sorry Social Media Stocks to Sell in February While You Still Can (InvestorPlace)
Feb-04-24 04:03AM	Chinese turn U.S. embassy post into 'Wailing Wall' for stock plunge (Reuters)
Jan-04-24 04:30AM	Beijing calls for halt to Myanmar fighting after stray artillery fire injured five in Chinese border town (South China Morning Post)
Dec-21-23 04:30AM	Elon Musk's X becomes top trending topic on China's Weibo after outage, taking many netizens by surprise (South China Morning Post)
01:32AM	UPDATE 1-A dozen still missing after China's earthquake, 137 dead (Reuters)
Dec-20-23 09:14PM	A dozen still missing after China's earthquake (Reuters)
Dec-18-23 08:36AM	Are Options Traders Betting on a Big Move in Weibo (WB) Stock? (Zacks)
Dec-14-23 11:18PM	Chinas Weibo Asks Bloggers to Avoid Badmouthing the Economy (Bloomberg)
Nov-30-23 08:56AM	Weibo Corporation Prices Offering of American Depositary Shares in connection with the Delta Placement of Borrowed ADSs (PR Newswire) -10.69%
08:55AM	Weibo Corporation Prices Offering of US$300 Million Convertible Senior Notes (PR Newswire)
Nov-29-23 04:21PM	Weibo Corporation Announces Proposed Offering of American Depositary Shares in connection with the Delta Placement of Borrowed ADSs (PR Newswire)
04:19PM	Loading…
04:19PM	Weibo Corporation Announces Proposed Offering of US$300 Million Convertible Senior Notes (PR Newswire)
Nov-27-23 11:16AM	UPDATE 1-China's Didi Global says ride-hailing app had 'systems malfunction' (Reuters)
02:05AM	Beijing frets over Taiwan opposition split as parties go on the attack over China ties (Reuters)
Nov-13-23 07:11PM	11 Cheap Chinese Stocks to Buy Right Now (Insider Monkey)
Nov-10-23 02:48PM	Weibo Corporation (NASDAQ:WB) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 09:30AM	Weibo Corporation (WB) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) -5.72%
04:00AM	Weibo Reports Third Quarter 2023 Unaudited Financial Results (PR Newswire)
Nov-02-23 02:46AM	Blackpinks Lisa, Angelababy Banned on Weibo After Risque Show (Bloomberg)
Nov-01-23 05:30AM	Chinese social media platforms Weibo, WeChat and Douyin's real-name authentication rule for influencers to benefit operations amid tightened online regulation, analysts say (South China Morning Post)
Oct-31-23 06:48PM	Leaker corroborates iPhone 16 capacitive capture button rumor (AppleInsider)
08:20AM	UPDATE 1-China removes anonymity of bloggers' accounts with more than 500,000 followers (Reuters)
07:11AM	Tencent, Kuaishou Demand Real Names in China Internet Tightening (Bloomberg)
Oct-27-23 12:23AM	The sudden death of China's former No. 2 leader Li Keqiang has shocked many (Associated Press Finance)
Oct-26-23 09:40AM	Should Value Investors Buy DHI Group (DHX) Stock? (Zacks)
Oct-25-23 11:40AM	WB vs. ABNB: Which Stock Is the Better Value Option? (Zacks)
09:55AM	Wall Street Analysts Think Weibo Corporation (WB) Could Surge 54.47%: Read This Before Placing a Bet (Zacks)
05:00AM	Weibo Corporation to Report Third Quarter 2023 Financial Results on November 9, 2023 (PR Newswire)
Oct-24-23 12:44AM	Chinas X-Like Service Asks Top Influencers to Show Real Names (Bloomberg) +6.09%
Oct-20-23 06:18AM	CEO of China's Weibo tests new real-name policy on his own account (Reuters)
Oct-05-23 12:01PM	5 Leading Social Media Companies In The Artificial Intelligence Theme (Insider Monkey)
Sep-30-23 10:50AM	China's lottery ticket sales soar amid weak economy, job prospects (Reuters)
Sep-22-23 12:35PM	Is Weibo (WB) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
Sep-07-23 05:30AM	China crypto crackdown: Weibo banishes 80 prominent cryptocurrency influencers (South China Morning Post) -5.72%
Aug-25-23 11:48AM	Is Weibo Corp (WB) a Hidden Value Trap? Unpacking the Risks and Rewards (GuruFocus.com) -8.83%
09:39AM	Weibo Corporation (NASDAQ:WB) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-24-23 05:15AM	Weibo Reports Second Quarter 2023 Unaudited Financial Results (PR Newswire)
Aug-18-23 04:36AM	The Voice of China Producer Falls by Record After Viral Video (Bloomberg)
Aug-09-23 05:00AM	Weibo Corporation to Report Second Quarter 2023 Financial Results on August 24, 2023 (PR Newswire)
Aug-08-23 04:20PM	Paramount earnings: Streamers' growth is 'certainly slowing,' analyst explains (Yahoo Finance Video)
Aug-01-23 11:54PM	Rescuers focus on flooded city south of Beijing after historic rains in north China (Reuters)
Jun-26-23 10:09PM	China Bans Negative Finance Writers as Stock Market Sinks (Bloomberg)
Jun-23-23 02:54PM	10 Stocks that Paid Special Dividends in 2023 (Insider Monkey)
May-25-23 05:00AM	Weibo Reports First Quarter 2023 Unaudited Financial Results and Dividend (PR Newswire)
May-24-23 04:30AM	Weibo Announces Results of 2023 Annual General Meeting (PR Newswire)
May-10-23 09:40AM	Is Perion Network (PERI) Stock Undervalued Right Now? (Zacks)
May-05-23 05:00AM	Weibo Corporation to Report First Quarter 2023 Financial Results on May 25, 2023 (PR Newswire)
May-01-23 11:40AM	WB vs. RELX: Which Stock Should Value Investors Buy Now? (Zacks)
Apr-27-23 05:30AM	Weibo Files its Annual Report on Form 20-F (PR Newswire)
Apr-21-23 06:43AM	BMW apologizes for its slipup at Shanghai auto show, after social media users accuse it of giving ice cream to foreigners and not locals (Fortune)
Apr-20-23 01:59AM	BMW skids into ice cream melee at Shanghai auto show (Reuters)
Apr-14-23 11:40AM	WB or SSTK: Which Is the Better Value Stock Right Now? (Zacks)
Apr-03-23 05:30AM	Weibo to Hold Annual General Meeting on May 24, 2023 (PR Newswire) -5.18%
Mar-31-23 05:30AM	Apple CEO Tim Cook's whistle-stop tour of Shanghai bolsters ties with Genshin impact creator miHoYo, other local app developers (South China Morning Post)
Mar-29-23 11:40AM	WB vs. ABNB: Which Stock Is the Better Value Option? (Zacks)
Mar-22-23 10:04AM	Implied Volatility Surging for Weibo (WB) Stock Options (Zacks)
Mar-21-23 11:45AM	U.S. State-Government Websites Use TikTok Trackers, Review Finds (The Wall Street Journal)
11:45AM	State-Government Websites Use TikTok Trackers, Review Finds (The Wall Street Journal)
10:00AM	TikTok Trackers Embedded in U.S. State-Government Websites, Review Finds (The Wall Street Journal)
Mar-06-23 10:13PM	Weibo Corporation (NASDAQ:WB) Q4 2022 Earnings Call Transcript (Insider Monkey)
04:30AM	China's social media sounds the alarm bell about India's development as Apple's next hub for iPhone manufacturing supply chain (South China Morning Post)
Mar-02-23 04:30AM	Beijing proxies voice support for TikTok as the ByteDance-owned video app faces bans in US, EU (South China Morning Post)
Mar-01-23 07:29AM	Weibo Q4 Highlights: 27% Revenue Decline, Margin Contraction Due To China's COVID Measures (Benzinga) -7.54%
04:45AM	Weibo Reports Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results (PR Newswire)
Feb-28-23 08:36AM	Is a Surprise Coming for Weibo (WB) This Earnings Season? (Zacks)
08:00AM	RESAAS Enables Real Estate Agents to Market Across Asia Using Sina Weibo, a Leading Social Media Platform in Asia (PR Newswire)
Feb-21-23 04:00PM	Tencent Becomes a Cant-Touch Stock for Some ESG Investors (Bloomberg)
Feb-15-23 04:00AM	Weibo Corporation to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 2023 (PR Newswire)
Jan-27-23 09:36AM	Weibo and Viasat have been highlighted as Zacks Bull and Bear of the Day (Zacks)
08:57AM	Weibo Corporation (WB) Surges 14.0%: Is This an Indication of Further Gains? (Zacks)
06:00AM	Bull of the Day: Weibo Corp. (WB) (Zacks)
Jan-23-23 11:40AM	WB vs. RELX: Which Stock Is the Better Value Option? (Zacks)
Dec-31-22 02:44AM	WRAPUP 1-China censors COVID-related content online as New Year's Eve prompts reflection by some (Reuters)
Dec-27-22 01:21PM	China stocks tell 2 different stories about the economy (Yahoo Finance) +8.82%
Dec-26-22 08:46PM	Weibo Corporation (NASDAQ:WB) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-21-22 11:35AM	Elon Musk posts cryptic message to Chinese social media site Weibo as he confirms Twitter exit plan (Fox Business)
Dec-14-22 01:19AM	Medical staff in China's hospitals say COVID-19 ripping through their ranks (Reuters)
Dec-13-22 01:10AM	Blizzard talking with potential partners to continue offering World of Warcraft in China (Reuters)
01:05AM	UPDATE 1-Blizzard talking with potential partners to continue offering World of Warcraft in China (Reuters)
Dec-07-22 04:56AM	'Daylight is here': China travel searches surge as public cheers COVID easing (Reuters) -5.15%
Dec-02-22 09:30AM	Is Weibo (WB) a Good Pick for Value Investors? (Zacks) +8.38%

Weibo Corp. engages in the creation, distribution, and discovery of Chinese-language content. It operates through the Advertising and Marketing Services, and Other Services segments. The company was founded in August 2009 and is headquartered in Beijing, China.

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

MYGN

Myriad Genetics, Inc.

WB

Weibo Corp ADR

Upgrade your FINVIZ experience